Aytu BioPharma, Inc. (AYTU)
2.00
+0.03
(+1.52%)
USD |
NASDAQ |
Oct 13, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Aytu BioPharma Profit Margin (Quarterly) : -0.09% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.09% |
| March 31, 2026 | -45.27% |
| December 31, 2025 | -69.79% |
| September 30, 2025 | 14.15% |
| June 30, 2025 | -131.4% |
| March 31, 2025 | 21.35% |
| December 31, 2024 | 4.10% |
| September 30, 2024 | 6.59% |
| June 30, 2024 | -23.15% |
| March 31, 2024 | -16.31% |
| December 31, 2023 | 3.30% |
| September 30, 2023 | -41.94% |
| June 30, 2023 | -7.99% |
| March 31, 2023 | -31.67% |
| December 31, 2022 | -25.47% |
| September 30, 2022 | -2.53% |
| June 30, 2022 | -58.62% |
| March 31, 2022 | -219.3% |
| December 31, 2021 | -49.94% |
| September 30, 2021 | -127.2% |
| June 30, 2021 | -80.90% |
| March 31, 2021 | -188.8% |
| December 31, 2020 | -62.89% |
| September 30, 2020 | -31.85% |
| June 30, 2020 | -21.16% |
| Date | Value |
|---|---|
| March 31, 2020 | -65.38% |
| December 31, 2019 | -6.75% |
| September 30, 2019 | -342.3% |
| June 30, 2019 | -847.0% |
| March 31, 2019 | -189.1% |
| December 31, 2018 | -259.5% |
| September 30, 2018 | -240.7% |
| June 30, 2018 | 59.19% |
| March 31, 2018 | -463.8% |
| December 31, 2017 | -349.4% |
| September 30, 2017 | -394.4% |
| June 30, 2017 | -363.7% |
| March 31, 2017 | -583.8% |
| December 31, 2016 | -606.5% |
| September 30, 2016 | -820.1% |
| June 30, 2016 | -1.63K% |
| March 31, 2016 | -1.09K% |
| December 31, 2015 | -710.2% |
| September 30, 2015 | -467.0% |
| March 31, 2015 | -7.74K% |
| February 28, 2015 | |
| November 30, 2014 | |
| August 31, 2014 | |
| May 31, 2014 | -1.18K% |
| February 28, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.22% |
| Return on Assets | -12.11% |
| Return on Invested Capital | -29.54% |
| Gross Profit Margin (Quarterly) | 59.90% |
| Operating Margin (Quarterly) | 1.87% |
| Return on Net Operating Assets | -16.81% |